Neoadjuvant chemotherapy with docetaxel, oxaliplatin, and S‐1 versus oxaliplatin and S‐1 for locally advanced gastric adenocarcinoma: A multicenter, real‐world cohort study

Documenti analoghi

• Efficacy and safety of camrelizumab combined with oxaliplatin and S‐1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single‐arm study
  di: Wen‐Jin Zhong, et al.
  Pubblicazione: (2024)
• Phase I trial of apatinib and paclitaxel+oxaliplatin+5‐FU/levoleucovorin for treatment‐naïve advanced gastric cancer
  di: Shen Zhao, et al.
  Pubblicazione: (2024)
• Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity
  di: Yujiao Hua, et al.
  Pubblicazione: (2024)
• Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model
  di: Kuan‐Hui Li, et al.
  Pubblicazione: (2024)
• Curcumin relieves oxaliplatin‐induced neuropathic pain via reducing inflammation and activating antioxidant response
  di: Meng‐Wei Zhang, et al.
  Pubblicazione: (2024)